Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

134.01 +2.56 (+1.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
$1000 Invested In This Stock 5 Years Ago Would Be Worth $7,000 Today
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
What to Expect from TransMedics Gr's Earnings
Via Benzinga
2 Growth Stocks to Buy Now That Are Flying Under the Radar
Being the leader in their respective markets could make these stocks top performers in the long run. 
Via The Motley Fool
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4
Via Benzinga
How Is The Market Feeling About TransMedics Gr?
Via Benzinga
Here's How Much $100 Invested In TransMedics Gr 5 Years Ago Would Be Worth Today
Via Benzinga
Looking Into TransMedics Gr's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning TransMedics Gr Stock In The Last 5 Years
Via Benzinga
Expert Ratings For TransMedics Gr
Via Benzinga
Dogecoin, Shiba Inu, Pepe May Have Overtaken These Nasdaq-Listed Companies Toward Billion-Dollar Valuations, But There's A Catch
Cryptocurrencies based on internet memes and online communities are jumping to billion-dollar valuations in record quick time, leaving behind corporate America in the process. 
Via Benzinga
2 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Both of these stocks should have plenty of room to run. 
Via The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $5,600 Today
Via Benzinga
(TMDX) - Analyzing TransMedics Gr's Short Interest
Via Benzinga
Why Shares of TransMedics Stock Plunged This Week
TransMedics' revolutionary Organ Care System, high sales growth, and newfound profitability combine with its towering valuation to create wild volatility. 
Via The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $7,400 Today
Via Benzinga
Navigating 10 Analyst Ratings For TransMedics Gr
Via Benzinga
Peering Into TransMedics Gr's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning TransMedics Gr Stock In The Last 5 Years
Via Benzinga
TransMedics' Technology Poised To Transform Underpenetrated $8B Organ Transplant Market, Analyst Expects 22% Upside
Needham initiated coverage on TransMedics, highlighting its Organ Care System technology and National OCS Program, which are revolutionizing organ transplants with strong revenue growth, projected... 
Via Benzinga
RxSight Stock Sees Relative Strength Rating Rise To 91
On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91. 
Via Investor's Business Daily
1 No-Brainer Growth Stock I Can't Wait to Buy Again if the Market Crashes
A long lead in a niche industry ripe for disruption could make this stock a top performer. 
Via The Motley Fool
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why TransMedics Group Stock Is Soaring Today
This medical technology disruptor continues to impress investors. 
Via The Motley Fool
Assessing TransMedics Gr: Insights From 6 Financial Analysts
Via Benzinga
$1000 Invested In TransMedics Gr 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much $100 Invested In TransMedics Gr 5 Years Ago Would Be Worth Today
Via Benzinga
Q3’s Rising Stars: 3 Growth Stocks for Your Must-Watch List
These growth stocks to watch exceeded analyst expectations in recent quarterly results and have ample opportunities to expand. 
Via InvestorPlace
8 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
TMDX Stock Earnings: TransMedics Gr Beats EPS, Beats Revenue for Q2 2024
TMDX stock results show that TransMedics Gr beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS